How can we help you?
Support Program Resources
Advancing Access® Patient Brochure
YEZTUGO® (lenacapavir) Advancing Access Patient Brochure
Advancing Access® Healthcare Provider Brochure
YEZTUGO Advancing Access Healthcare Provider Brochure
iAssist Step-by-Step Guide
YEZTUGO Co-pay Savings Program Overview
Forms and Templates
Advancing Access® Support Program
Advancing Access is a patient support program. It can help you find financial support options and understand coverage information for your prescribed Gilead HIV treatment, HIV prevention, or COVID-19 medication.
- Co-pay Savings Program
- Medication Assistance Program (MAP)
- Learn how to insurance may cover your medication
- Help with prior authorization and appeals process information
- Information on additional support and coverage options
Advancing Access program specialists can conduct a benefits investigation to help you and your patient understand their insurance coverage and any prior authorization or appeals process requirements. In the Support Resources of the Forms and Templates section of this page, you will find sample letters of medical necessity and appeal, as well as a prior authorization checklist and Injectable forms.
If you or your staff would like to learn more about the Advancing Access program and the program support available to your patients, please call the program at 1-800-226-2056 to set up a training webinar.
Ways to get started:
- Enroll online
- Download an enrollment form. Fax it to the number on the form. Choose your enrollment form:
- Call Advancing Access® at 1-800-226-2056
To register, go to https://advancingaccess.iassist.com/register and follow the steps. If you need help registering, please call the iAssist helpdesk at 1-877-450-4412 for assistance.
All required sections of the enrollment form, along with your signature and your patient’s signature, are required to be completed.
Advancing Access will send a fax to your office letting you know if your patient was eligible for MAP. Additionally, we will let your patient know via their preferred communication method listed on their enrollment form.
Medication Assistance Program (MAP)
The Gilead Advancing Access Medication Assistance Program (MAP) provides prescribed HIV prevention medication free of charge to eligible individuals.
Advancing Access will notify you and your patient if they were eligible based on the preferred communication method your patient listed on the enrollment form.
To be eligible to enroll into MAP, individuals need to be residents of the United States, Puerto Rico, or US Territories, in addition to meeting other eligibility criteria. Proof of residency may be required.
Standard MAP enrollment is for up to 12 months, pending ongoing eligibility checks.
If there is ongoing need for support and the patient remains eligible for MAP, then they can re-enroll.
Advancing Access will reach out to you and your patient 60 days prior to the enrollment end date.
There are several ways to re-enroll eligible individuals into MAP. You can fax in a new enrollment form or, if you are a registered user of the online enrollment portal, you may be able to re-enroll eligible individuals electronically.
Many individuals who need ongoing MAP support can be re-enrolled through the online enrollment portal. Follow these steps:
1. Log in to the portal as you normally would
2. On the HOME screen, click on DRAFTS - located in the panel on the left side of the screen
3. Once in the drafts section, click on Re-Verification Drafts. Select or search for specific individual
4. Click on the appropriate individual. You will be routed to the re-enrollment service offering
If you have questions about using this process, please call an Advancing Access® program specialist at 1-800-226-2056.
Please notify Advancing Access by calling 1-800-226-2056 to have the individual withdrawn from MAP.
- You can use the online enrollment portal, which will give you an immediate determination of an individual’s MAP eligibility
- You can fax a completed enrollment form to the number on the form. All faxed enrollment forms are reviewed in the order they are received, and you will be notified within 2 business days with a determination of eligibility. Choose your enrollment form:
- Or, if there is an urgent need to get your patient started, please call an Advancing Access® program specialist at 1-800-226-2056
How MAP prescriptions are filled
As of May 5, 2025, anyone enrolled in the Advancing Access free drug program can receive their prescribed Gilead medicines via mail. Once a shipment address is confirmed, prescriptions will be mailed as soon as one business day via FedEx overnight delivery to an enrollee’s location of choice to address any privacy concerns—either their home, an alternate address such as a shelter, clinic, FedEx pick-up location, or their healthcare provider’s office should the healthcare provider agree.
New enrollees to Advancing Access may have the option of a 30-day supply of our medicines from a retail pharmacy. Following this first month's fill via retail, the free drug program enrollee will then receive their Gilead medication via mail.
For more details on how to receive your prescription as Gilead is transitioning its Advancing Access free drug program from a retail pharmacy model to a mail order delivery model, please see the FAQs section, Mail order updates, or call 1-800-226-2056
There are over 40,000 participating retail pharmacies. While using the Pharmacy Finder, enter the pharmacy name and ZIP code to see if the patient’s pharmacy participates in MAP. If they don’t already have a pharmacy, they can enter their ZIP code to find participating pharmacies near them.
If your patient would like their medication sent directly to them, they can select “mail order delivery” while filling out the enrollment form. Your patient can also call Advancing Access at 1-800-226-2056 for assistance.
Co-pay Savings Program
The Gilead Co-pay Savings Program may help eligible, commercially insured individuals lower their out-of-pocket (OOP) costs. It is not available to your patient if they are enrolled in any federally- or state-funded prescription drug program, such as Medicare, Medicare Part D, or Medicaid. For more information and to see if your patient is eligible, view co-pay program benefits and terms and conditions.
The coverage amount varies depending on the medication. For injectable PrEP, you may need to submit a claim for product and/or injection administration reimbursement through the Co-pay Savings Program portal. Detailed instructions will be provided at enrollment. For the most up-to-date amounts, view co-pay program benefits and terms and conditions.
No, the co-pay savings card does not expire. Once your patient is enrolled in the co-pay program, your patient keeps the same card for the duration of their enrollment in the program. For information about the annual coverage amount for the co-pay program, please visit the co-pay program page.
The patient can go to Replace a Card on the co-pay program page. If help is still needed, the patient can call an Advancing Access program specialist at 1-800-226-2056.
If the patient has not yet activated that card, the patient can go to Enroll on the co-pay program page. If the patient had already activated the card but lost it, the patient should select Replace to retrieve card information. If help is still needed, call an Advancing Access program specialist at 1-800-226-2056.
If a patient is prescribed a different Gilead HIV treatment or HIV prevention medication, they can continue to use the same card for the new medication. However, SUNLENCA® (lenacapavir) has its own specific Co-pay Savings Program cards for which the patient must enroll separately.
